IFCC - Scientific Division (SD)

SD Executive Committee:
From left to right:
Heinz Schimmel - JRC Observer; Mario Plebani - Member; Konstantinos Makris - Member; Philippe Gillery - Chair; Paola Bramati - IFCC office; Gary Myers - JCTLM Consultant; Joseph Passarelli - Secretary; Christa Cobbaert - Vice Chair; Tsutomu Nobori - Member
The Scientific Division (SD)
A Committee on Standards was established in 1966 "to instigate and promote theoretical and practical developments in the field of standards and standardisation in clinical chemistry - in its broadest sense." During its first decade, the main efforts of the Committee were directed toward analytical nomenclature, reference materials and methods, and quality control. Its achievements during this period are illustrated by the list of publications on these topics. Following a Council decision in 1978, efforts have been made to extend its work to include more subjects of interest both to clinicians and clinical chemists. Accordingly, the name of the Committee was changed to the Scientific Committee and later to the Scientific Division.
Mission Statement
The mission of the SD is to advance the science of Clinical Chemistry and to apply it to the practice of Clinical Laboratory Medicine.
SD Strategy
According to the Statutes of IFCC, the Federation exists to advance the science and practice of Clinical Chemistry and to further its application in the provision of health services and the practice of medicine. The goals to which the Scientific Division is committed are to:
- Identify research areas of relevance to Clinical Chemistry and Laboratory Medicine and assist the transfer of research results to the profession.
- Identify scientific and technological problems in current practice and provide solutions and guidelines on how to resolve them.
- Facilitate the development and transfer of technical innovations to clinical laboratory professionals and clinicians.
- Facilitate the development and implementation of diagnostic strategies.
- Establish standards for scientific and technical aspects of good laboratory practice.
- Respond to scientific and technical needs of IFCC Member Societies, IFCC Corporate Members and external agencies.
- Participate actively in the scientific programs of IFCC congresses and other scientific meetings.
- Ensure the quality of IFCC scientific documents.
- Organise Master Discussions.
SD Projects
The SD initiates and manages projects with its own resources or through its Committees and Working Groups. Work is conducted in cooperation with other IFCC units and with relevant National and International Organisations. The SD ensures that each of its Committees and Working Groups are functioning under clear terms of reference together with an agreed schedule of activity. The SD will assist in the development of the project proposals, and will undertake an annual review of progress and review and approve any documents that result from the work.
SD Executive Committee (SD-EC)
| Name |
Position |
Country |
Term |
Time in Office |
| P. Gillery |
Chair |
FR |
1st |
2017 01 - 2019 12 |
| C.M. Cobbaert |
Vice-Chair |
NL |
1st |
2017 01 - 2019 12 |
| J. Passarelli |
Secretary |
US |
1st |
2015 01 - 2017 12 |
| K. Makris |
Member |
GR |
1st |
2017 01 - 2019 12 |
| T. Nobori |
Member |
JP |
1st |
2015 02 - 2017 12 |
| M. Plebani |
Member |
IT |
1st |
2017 02 - 2019 12 |
| J.F. Pierson-Perry |
Corporate Member |
US |
1st |
2015 02 - 2017 12 |
| G. Myers |
JCTLM Chair / SD Consultant |
US |
|
|
| H. Schimmel |
JRC Observer |
BE |
| C. Burns |
NISBC Consultant |
UK |
| To be nominated |
NIST Consultant |
US |
CHAIRS OF SCIENTIFIC DIVISION COMMITTEES AND WORKING GROUPS
Committees
| 8.2.6 |
Nomenclature, Properties and Units (C-NPU) in collaboration with International Union of Pure and Applied Chemistry (IUPAC) |
R. Flatman (AU) |
| 8.2.11 |
Molecular Diagnostics (C-MD) |
D. Payne (US) |
| 8.2.23 |
Traceability in Laboratory Medicine (C-TLM) |
L. Siekmann (DE) |
| 8.2.24 |
Reference Intervals and Decision Limits (C-RIDL) |
Y. Ozarda (TR) |
| 8.2.25 |
Thyroid Function Tests (C-STFT) |
L. Thienpont (BE) |
| 8.2.26 |
Harmonization of Autoimmune Tests (C-HAT) |
To be appointed |
Working Groups
| 8.3.35. |
Standardisation of Hemoglobin A2 (WG-HbA2) |
R. Paleari (IT) |
| 8.3.36 |
Standardisation of Carbohydrate-Deficient Transferrin (WG-CDT) |
J. Wielders (NL) |
| 8.3.39 |
Standardisation of Albumin Assay in Urine (WG-SAU) in collaboration with National Kidney Disease Education Program (NKDEP) |
L. Bachmann (US) |
| 8.3.40 |
Standardisation of Pregnancy-Associated Plasma Protein A (WG-PAPP A) |
S. Wittfooth (UK) |
| 8.3.41 |
Growth-Hormone (WG-GH) |
E. Lentjes (NL) |
| 8.3.42 |
Standardisation of Insulin Assays (WG-SIA) in collaboration with American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD) |
A. Saenger (US) |
| 8.3.43. |
Standardisation of Troponin I (WG-TNI) |
D. Bunk (US) |
| 8.3.48 |
Parathyroid Hormone (WG-PTH) |
C. Sturgeon (UK) |
| 8.3.49 |
CSF Proteins (WG-CSF) |
K. Blennow (SE) |
| 8.3.50 |
Standardisation of Bone Markers Assays (WG-BMA) |
H. Morris (AU) |
| 8.3.51 |
Commutability (WG-C) |
G. Miller (US) |
| 8.3.53 |
Immunosuppressive Drugs (WG-ID) |
To be appointed |
| 8.3.54 |
Apolipoproteins by Mass Spectrometry (WG-APO MS) |
C. Cobbaert (NL) |
| 8.3.55 |
Pancreatic Enzymes (WG-PE) |
D. Grote-Koska (DE) |
| 8.3.56 |
Fecal Immunochemical Testing (WG-FIT) |
S. Benton (UK) |
SD Executive Committe's contacts
|
CHAIR
Prof. Philippe GILLERY Laboratoire de Biologie et de Recherche Pédiatriques Hôpital Maison Blanche CHU de Reims 45 rue Cognacq Jay 51092 Reims Cedex France Tel: +33 3 2678 3952 Fax: +33 3 2678 3882 E-mail: pgillery@chu-reims.fr
|
VICE-CHAIR
Prof. Christa M. COBBAERT Clinical Chemist Head of the Department of Clinical Chemistry Leiden University Medical Center Postbus 9600 Postzone E2-P 2300 RC Leiden The Netherlands Tel: +31 71 5262278/+31 71 5264483 Fax : +31 71 E-mail: C.M.Cobbaert@lumc
|
|
SECRETARY
Mr. Joseph PASSARELLI Scientific Relations, Research and Development Roche Diagnostics Corporation 9115 Hague Road, PO Box 50416 Indianapolis, Indiana 46250-0416 USA Tel: +1 317 521 4206 Fax: +1 317 521 2324 Mobile: +1-317-625-7810 E-mail: joseph.passarelli@roche.com
|
MEMBER
Dr. Konstantinos MAKRIS Clinical Biochemist Clinical Biochemistry Department KAT General Hospital 2 Nikis street, 14561 Kifissia, Athens Greece Phone: +30-213-2086701 Mobile: +30-6972207867 e-mail: kostas.makris.km@gmail.com
|
|
MEMBER
Prof. Tsutomu NOBORI Professor Emeritus, Mie University Oyamada Memorial Spa Hospital 5538-1 Yamada-cho, Yokkaichi Mie 512-1111 Japan Tel: (+81) 59-328-1260 Fax: (+81)59-328-1921 e-mail: nobori@clin.medic.mie-u.ac.jp
|
MEMBER
Prof. Mario PLEBANI Full Professor of Clinical Biochemistry and Clinical Molecular Biology Chief Department of Laboratory Medicine University Hospital - Padova Dean of the Medical School University of Padova Italy E-mail: mario.plebani@unipd.it
|
|
CORPORATE REPRESENTATIVE
Mr. James F. PIERSON-PERRY Principal Key Expert Global Assay Development, Glasgow Site Siemens Healthcare Diagnostics USA Tel: +302.631.7692 Cel: +302.229.6462 Fax: +302.631.7487 e-mail: james.f.pierson-perry@siemens.com
|
JCTLM CONSULTANT
Dr. Gary L. MYERS Chair, JCTLM 4711 Derby Lane Smyrna, GA 30082 USA Tel: +404-457-5804 E-mail: gmyers1049@yahoo.com
|
|
EUROPEAN COMMISSION - JRC OBSERVER
Dr. Heinz SCHIMMEL Project Officer Directorate General Joint Research Centre Directorate F – Health, Consumers and Reference Materials Reference Materials Unit Retieseweg 111 2440 Geel Belgium Tel: +32 (0)14 571 720 E-mail: heinz.schimmel@ec.europa.eu
|
NISBC CONSULTANT
Dr. Chris BURNS Head, Biotherapeutics Division National Institute for Biological Standards and Control (NIBSC) A Centre of the MHRA Blanche Lane South Mimms, Potters Bar Hertfordshire, EN6 3QG UK Tel: 01707 641247 Email: Chris.Burns@nibsc.org
|
|
NIST CONSULTANT
To be nominated
|
|
| |
|